- Report
- March 2025
- 136 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- August 2025
- 196 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- February 2025
- 135 Pages
Global
From €2646EUR$2,999USD£2,289GBP
- Report
- August 2025
- 181 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- August 2025
- 191 Pages
Global
From €3128EUR$3,545USD£2,705GBP
€3476EUR$3,939USD£3,006GBP
- Report
- September 2025
- 377 Pages
Global
From €5162EUR$5,850USD£4,465GBP
- Report
- September 2023
- 50 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- April 2023
- 120 Pages
Global
From €4191EUR$4,750USD£3,625GBP
- Report
- November 2021
- 111 Pages
Global
From €3971EUR$4,500USD£3,434GBP
- Report
- July 2024
- 154 Pages
Global
From €3188EUR$3,613USD£2,757GBP
€3750EUR$4,250USD£3,243GBP
- Report
- February 2024
- 48 Pages
Global
From €2206EUR$2,500USD£1,908GBP
- Report
- January 2024
- 85 Pages
Global
From €3500EUR$4,249USD£3,133GBP
- Report
- March 2023
- 78 Pages
Global
From €3500EUR$4,249USD£3,133GBP
- Book
- November 2024
North America

The Cardiac Marker Rapid Test market is a subset of the Point-of-Care Diagnostics market, which focuses on providing quick and accurate results for medical tests. These tests are typically used to diagnose cardiac conditions, such as myocardial infarction, and are often used in emergency situations. Cardiac Marker Rapid Tests are designed to detect the presence of cardiac markers, such as troponin, in a patient's blood sample. These tests are typically performed in a clinical setting, such as a hospital or doctor's office, and provide results in a matter of minutes.
Some companies in the Cardiac Marker Rapid Test market include Abbott, Roche, Siemens, and Beckman Coulter. Show Less Read more